Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next

Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next

Endocrinologist Jennifer Green discusses how GLP-1 drugs, like Ozempic, evolved from diabetes tools to potential treatments for addiction and heart disease, in this final installment of the obesity series. The discussion also touches on critical questions about long-term use, access, and emerging innovations. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-5-connecting-dots-broader-applications-glp-1s-and-where-were-headed-next

Episoder(45)

Populært innen Vitenskap

fastlegen
rekommandert
jss
tingenes-tilstand
rss-rekommandert
liberal-halvtime
sinnsyn
forskningno
tomprat-med-gunnar-tjomlid
villmarksliv
rss-nysgjerrige-norge
fjellsportpodden
dekodet-2
kvinnehelsepodden
smart-forklart
rss-paradigmepodden
vett-og-vitenskap-med-gaute-einevoll
nevropodden
tidlose-historier
utenrikshospitalet